Literature DB >> 22219130

Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Mak Adam Daulatzai1.   

Abstract

The pathophysiological mechanism(s) underlying Alzheimer's disease (AD) still remain unclear, and no disease-modifying or prophylactic therapies are currently available. Unraveling the fundamental neuropathogenesis of AD is an important challenge. Several studies on AD have suggested lesions in a number of CNS areas including the basal forebrain, hippocampus, entorhinal cortex, amygdale/insula, and the locus coeruleus. However, plausible unifying studies on the upstream factors that involve these heterogeneous regions and herald the onset of AD pathogenesis are not available. The current article presents a novel nucleus tractus solitarius (NTS) vector hypothesis that underpins several disparate biological mechanisms and neural circuits, and identifies relevant hallmarks of major presumptive causative factor(s) linked to the NTS, in older/aging individuals. Aging, obesity, infection, sleep apnea, smoking, neuropsychological states, and hypothermia-all activate inflammatory cytokines and oxidative stress. The synergistic impact of systemic proinflammatory mediators activates microglia and promotes neuroinflammation. Acutely, the innate immune response is protective defending against pathogens/toxins; however, when chronic, it causes neuroinflammation and neuronal dysfunction, particularly in brainstem and neocortex. The NTS in the brainstem is an essential multiple signaling hub, and an extremely important central integration site of baroreceptor, chemoreceptor, and a multitude of sensory afferents from gustatory, gastrointestinal, cardiac, pulmonary, and upper airway systems. Owing to persistent neuroinflammation, the dysfunctional NTS exerts deleterious impact on nucleus ambiguus, dorsal motor nucleus of vagus, hypoglossal, parabrachial, locus coeruleus and many key nuclei in the brainstem, and the hippocampus, entorhinal cortex, prefrontal cortex, amygdala, insula, and basal forebrain in the neocortex. The neuronal and synaptic dysfunction emanating from the inflamed NTS may affect its interconnected pathways impacting almost the entire CNS--which is already primed by neuroinflammation, thus promoting cognitive and neuropsychiatric symptoms. The upstream factors discussed here may underpin the neuropathopgenesis of AD. AD pathology is multifactorial; the current perspective underscores the value of attenuating disparate upstream factors--in conjunction with anticholinesterase, anti-inflammatory, immunosuppressive, and anti-oxidant pharmacotherapy. Amelioration of the NTS pathology may be of central importance in countering the neuropathological cascade of AD. The NTS, therefore, may be a potential target of novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219130     DOI: 10.1007/s11064-011-0680-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  323 in total

1.  Management of uncontrollable hypertension with a carotid sinus stimulation device.

Authors:  Markus G Mohaupt; Jürg Schmidli; Friedrich C Luft
Journal:  Hypertension       Date:  2007-09-24       Impact factor: 10.190

2.  Piriform cortex efferents to the entorhinal cortex in vivo: kindling-induced potentiation and the enhancement of long-term potentiation by low-frequency piriform cortex or medial septal stimulation.

Authors:  A Chapman; R J Racine
Journal:  Hippocampus       Date:  1997       Impact factor: 3.899

3.  Cytokine-induced activation of glial cells in the mouse brain is enhanced at an advanced age.

Authors:  X-H Deng; G Bertini; Y-Z Xu; Z Yan; M Bentivoglio
Journal:  Neuroscience       Date:  2006-05-30       Impact factor: 3.590

4.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

5.  Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction.

Authors:  W Zhang; B S Huang; F H Leenen
Journal:  Am J Physiol       Date:  1999-05

Review 6.  Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?

Authors:  Wolfgang Härtig; Andreas Bauer; Kurt Brauer; Jens Grosche; Tibor Hortobágyi; Botond Penke; Reinhard Schliebs; Tibor Harkany
Journal:  Rev Neurosci       Date:  2002       Impact factor: 4.353

7.  Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.

Authors:  Elina Zotova; James Ar Nicoll; Raj Kalaria; Clive Holmes; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2010-01-22       Impact factor: 6.982

8.  Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.

Authors:  R Bernard; I A Kerman; R C Thompson; E G Jones; W E Bunney; J D Barchas; A F Schatzberg; R M Myers; H Akil; S J Watson
Journal:  Mol Psychiatry       Date:  2010-04-13       Impact factor: 15.992

9.  Somatostatin immunoreactivity in axon terminals in rat nucleus tractus solitarii arising from central nucleus of amygdala: coexistence with GABA and postsynaptic expression of sst2A receptor.

Authors:  S Saha; Z Henderson; T F C Batten
Journal:  J Chem Neuroanat       Date:  2002-06       Impact factor: 3.052

10.  Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease.

Authors:  Roland von Känel; Joel E Dimsdale; Sonia Ancoli-Israel; Paul J Mills; Thomas L Patterson; Christine L McKibbin; Christopher Archuleta; Igor Grant
Journal:  J Am Geriatr Soc       Date:  2006-03       Impact factor: 5.562

View more
  20 in total

Review 1.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

Review 2.  Relationship between cognitive function and regulation of cerebral blood flow.

Authors:  Shigehiko Ogoh
Journal:  J Physiol Sci       Date:  2017-02-03       Impact factor: 2.781

Review 3.  Regulation of memory - from the adrenal medulla to liver to astrocytes to neurons.

Authors:  Paul E Gold
Journal:  Brain Res Bull       Date:  2014-01-07       Impact factor: 4.077

Review 4.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 5.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 6.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

Review 7.  Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-02-12       Impact factor: 3.911

Review 8.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

Review 9.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

Review 10.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.